Add-Aspirin: A Trial Assessing the Effects of Aspirin on Disease Recurrence and Survival After Primary Therapy in Common Non Metastatic Solid Tumours

Clinical trial NCT02804815 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT02804815
Sponsor: University College, London
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Cancer Breast Cancer Prostate Cancer Colorectal Cancer Gastro-oesophageal Cancer

Start date: 2015-10-01
Primary completion: 2026-10-01
Enrollment: 11000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.